Theralase Technologies Inc.
TLT.V
TSX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 27.83% | 150.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 27.83% | 150.08% | |||
| Cost of Revenue | 19.97% | 34.62% | |||
| Gross Profit | 34.38% | 822.58% | |||
| SG&A Expenses | 2.76% | -14.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.25% | -21.49% | |||
| Operating Income | -5.06% | 31.99% | |||
| Income Before Tax | -6.77% | 32.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -6.77% | 32.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.77% | 32.87% | |||
| EBIT | -5.06% | 31.99% | |||
| EBITDA | -4.74% | 32.76% | |||
| EPS Basic | -3.57% | 31.71% | |||
| Normalized Basic EPS | -5.88% | 34.62% | |||
| EPS Diluted | -3.57% | 31.71% | |||
| Normalized Diluted EPS | -5.88% | 34.62% | |||
| Average Basic Shares Outstanding | 0.84% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.84% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||